Physician profile
Caroline Marie Chebli
NPI 1740204122
$82,627.52
in general payments reported to CMS, 2019-2025
13 companies · $15K in 2025
The $15K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,018 · 2020: $1,459 · 2021: $1,235 · 2022: $26K · 2023: $20K · 2024: $17K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $47K · Food and Beverage: $3,252 · Travel and Lodging: $1,690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $46,948.33 |
| Food and Beverage | $3,251.61 |
| Travel and Lodging | $1,690.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $51,076.55 | 2022-2025 | Catalyst Total Csr, Catalyst Csr Shoulder System, R1 Reverse Total Shoulder |
| Fh Orthopedics, INC. | $15,199.09 | 2022-2023 | Arrow |
| Restor3d, INC. | $9,138.39 | 2024-2025 | |
| Mvp Orthopedics INC | $4,177.05 | 2019-2023 | |
| Stryker Corporation | $1,228.77 | 2019-2025 | Variax, Gamma, T2 |
| Kci USA, INC. | $400.00 | 2020 | |
| Smith+Nephew, INC. | $385.33 | 2024-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Coastal Medical Technologies LLC | $259.28 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $258.52 | 2024 | Rosa, Gel-One Cross-Linked Hyaluronate, Persona |
| Medical Device Business Services, INC. | $165.08 | 2024-2025 | Vistaseal, Actis |
| Sanara Medtech INC. | $126.81 | 2025 | Celleraterx |
| Exactech, INC. | $106.65 | 2019 | |
| Highridge Medical LLC | $106.00 | 2024 | Biomet Ebi Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$500.07 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Chebli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.